Immune Pharmacytes: Nanoparticle-Modified Leukocytes for Immunotherapy

The invention provides compositions and methods for delivering agents to localized regions, tissues, or organs in vivo by conjugating agent-loaded nanoparticles to cells having homing capability. The agents may be therapeutic or diagnostic agents such as cancer chemotherapeutic agents and imaging agents respectively.

Researchers

Darrell J Irvine / Anna Bershteyn / Jae Hyun (James) Moon / Matthias Stephan

Technology Areas: Diagnostics: Imaging Agents / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Small Molecules
Impact Areas: Healthy Living

  • methods and compositions for localized agent delivery
    United States of America | Granted | 9,393,199
  • methods and compositions for localized agent delivery
    United States of America | Granted | 9,283,184

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.